Rautenberg TA - Search Results

1

Evaluating the cost utility of racecadotril in addition to oral rehydration solution versus oral rehydration solution alone for children with acute watery diarrhea in four low middle-income countries: Egypt, Morocco, Philippines and Vietnam.

Rautenberg TA, Downes M, Kiet PHT, Ashoush N, Dennis AR, Kim K. Rautenberg TA, et al. J Med Econ. 2022 Jan-Dec;25(1):274-281. doi: 10.1080/13696998.2022.2037918. J Med Econ. 2022. PMID: 35125049 Free article.

2

Health Economic Decision Tree Models of Diagnostics for Dummies: A Pictorial Primer.

Rautenberg T, Gerritsen A, Downes M. Rautenberg T, et al. Diagnostics (Basel). 2020 Mar 14;10(3):158. doi: 10.3390/diagnostics10030158. Diagnostics (Basel). 2020. PMID: 32183372 Free PMC article.

3

Meta-analysis of health state utility values measured by EuroQol 5-dimensions (EQ5D) questionnaire in Chinese women with breast cancer.

Rautenberg T, Hodgkinson B, Zerwes U, Downes M. Rautenberg T, et al. BMC Cancer. 2022 Jan 10;22(1):52. doi: 10.1186/s12885-021-09140-5. BMC Cancer. 2022. PMID: 35012457 Free PMC article.

4

Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China.

Tamlyn Anne R, Downes M, Simoncini T, Yu Q, Ren M, Wang Y, Graziano CM, Kim K. Tamlyn Anne R, et al. J Med Econ. 2024 Jan-Dec;27(1):16-26. doi: 10.1080/13696998.2023.2289297. Epub 2023 Dec 11. J Med Econ. 2024. PMID: 38037348 Free article.

5

Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models.

Rautenberg TA, George G, Bwana MB, Moosa MS, Pillay S, McCluskey SM, Aturinda I, Ard K, Muyindike W, Moodley P, Brijkumar J, Johnson BA, Gandhi RT, Sunpath H, Marconi VC, Siedner MJ. Rautenberg TA, et al. J Med Econ. 2020 Mar;23(3):221-227. doi: 10.1080/13696998.2019.1705314. Epub 2020 Jan 11. J Med Econ. 2020. PMID: 31835974 Free PMC article.

6

The cost utility and budget impact of adjuvant racecadotril for acute diarrhea in children in Thailand.

Rautenberg TA, Zerwes U. Rautenberg TA, et al. Clinicoecon Outcomes Res. 2017 Jul 17;9:411-422. doi: 10.2147/CEOR.S140902. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28761363 Free PMC article.

7

Cost utility, budget impact, and scenario analysis of racecadotril in addition to oral rehydration for acute diarrhea in children in Malaysia.

Rautenberg TA, Zerwes U, Lee WS. Rautenberg TA, et al. Clinicoecon Outcomes Res. 2018 Mar 15;10:169-178. doi: 10.2147/CEOR.S157606. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 29588606 Free PMC article.

8

Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer.

Rautenberg T, Siebert U, Arnold D, Bennouna J, Kubicka S, Walzer S, Ngoh C. Rautenberg T, et al. J Med Econ. 2014 Feb;17(2):99-110. doi: 10.3111/13696998.2013.864973. Epub 2013 Dec 3. J Med Econ. 2014. PMID: 24215550 Free article.

9

Letter to the editor: author response.

Rautenberg T. Rautenberg T. J Med Econ. 2014 Jun;17(6):443. doi: 10.3111/13696998.2014.909680. Epub 2014 Apr 11. J Med Econ. 2014. PMID: 24724705 Free article. No abstract available.

10

Evaluating the cost utility of racecadotril for the treatment of acute watery diarrhea in children: the RAWD model.

Rautenberg TA, Zerwes U, Foerster D, Aultman R. Rautenberg TA, et al. Clinicoecon Outcomes Res. 2012;4:109-16. doi: 10.2147/CEOR.S31238. Epub 2012 Apr 20. Clinicoecon Outcomes Res. 2012. PMID: 22570557 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page